Skip to content

Early and Systematic Shoulder Rehabilitation Following Cervical Lymph Node Dissection

Early and Systematic Shoulder Rehabilitation Following Cervical Lymph Node Dissection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03961802
Acronym
RESYSTE
Enrollment
120
Registered
2019-05-23
Start date
2019-07-02
Completion date
2023-11-16
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rehabilitation

Keywords

Rehabilitation, shoulder dysfunction, cervical lymph node dissection, head and neck cancer

Brief summary

A prospective, monocentric, controlled, randomized study of systematic early shoulder rehabilitation following cervical lymph node dissection for the prevention and treatment of shoulder dysfunction.

Detailed description

Pre-inclusion: information, collection of consent, collection of antecedents and biometric data, clinical examination (goniometric measurement and visual analogic scale of pain), collection of DASH, EORTC QLQ-C30 and H&N35 questionnaires. Surgical intervention (J0) and randomization into 2 groups: Group 1 - systematic early rehabilitation Group 2 - without systematic rehabilitation M3, M6, M12: collection of complications, adjuvant treatments, number of physiotherapy sessions performed, clinical examination (goniometric measurement and visual analogic scale of pain), collection of DASH, EORTC QLQ- C30 and H&N35 questionnaires.

Interventions

OTHERsessions of shoulder rehabilitation

3 sessions of shoulder rehabilitation per week for 3 months (36 sessions)

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Proficiency in the oral and written French language * unilateral or bilateral cervical lymph node dissection preserving the accessory spinal nerve * Karnofsky index ≥ 80% * Age ≥ 18 years

Exclusion criteria

* cognitive disorders * predictable difficulties in compliance with treatment and/or follow-up * pre-existing pathology involving shoulder and its mobility, independent of head and neck cancer * comorbidity preventing rehabilitation of the shoulder * time to start rehabilitation after 6 weeks postoperatively * pregnant women * minors * majors under guardianship * refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Disabilities of Shoulder, Arm and Hand Questionnaire (DASH)6 months postoperatively (M6)The total score is reported. The score is between 0 and 100. The higher the score, the higher the disability.

Secondary

MeasureTime frameDescription
visual analog score for pain (M3, M6 and M12)3, 6 and 12 months postoperatively (M3, M6 and M12)The reported score is between 0 and 10. The higher the score, the higher the pain.
goniometric measurement of flexion and abduction of the shoulder3, 6 and 12 months postoperatively (M3, M6 and M12)Goniometric measurement will be performed using a Rippstein's Plurimeter, with standardized position and movement for each measurement: * Sitting on a chair, the bust is straight, arm hanging down the body. * The plurimeter is placed on the distal part of the arm. * The flexion is in the sagittal plane around a transverse axis in the frontal plane. * The abduction is in the frontal plane around an anteroposterior axis contained in the sagittal plane.
Disabilities of Shoulder, Arm and Hand Questionnaire (DASH)3 and 12 months postoperatively (M3 and M12)The total score is reported. The score is between 0 and 100. The higher the score, the higher the disability.
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck cancer module (H&N35)3, 6 and 12 months postoperatively (M3, M6 and M12)EORTC QLQ-H&N35 questionnaire evaluates the specific symptoms of patients with head and neck cancers. It consists of 35 items including 7 subscales . subscale scores are reported, All items and scales give a score between 0 and 100. For each subscale, a high score indicates the presence of a large number of specific symptoms, acting as factors of deterioration of certain aspects of the quality of life.
evaluate the compliance of patients to rehabilitation12 months postoperatively (M12)(% of rehabilitation sessions performed over 36 sessions)
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)3, 6 and 12 months postoperatively (M3, M6 and M12)EORTC QLQ-C30 questionnaire has 30 questions and includes the following scale: \- health and overall quality of life, scale have a score between 0 and 100. A high score indicates the preservation of a good quality of life.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026